Dear Medical Devices Group member,
 
As a leading international company in the MedTech space, we share your enthusiasm for developing and bringing new medical technology and improved medical practices to physicians and patients around the world.
 
There is a faster, better and much simpler way to bring your product(s) to market. Any market. A way to obtain and own your product premarket approval independently of your distributor and generate additional revenue from multiple market access simultaneously.
 
LICENSALE.COM® has been used by small-sized to large multinational MedTech companies for over three years now, and it has proved to reduce overall regulatory costs by as much as 50% and expedite time-to-market by 100%.
 
It is the only online regulatory platform that provides:
 
• The most up-to-date, device specific regulatory intelligence for 100+ countries
• A license application template for each type of device in each market
• Online application preparation services including documents review by qualified experts
• A document manager and archiving tools
• Project management and progress reports
• Final dossier preparation
• Submission to authorities
• Local authorized representative and independent license holder
• Post marketing, license maintenance and renewal activities
 
We feel responsible for bringing this information to you and urging you or someone on your behalf to have a closer look at this technology. We are confident that it would significantly contribute to the success of your company and your professional career. Schedule a demo today, and see for yourself why everyone is talking about LICENSALE.COM®.


Benny Arazy
President & CEO

 
latest news
  • Jul 17 2017
    REGULATORY UPDATE - XERIDIEM

    UAE: Xeridiems' Entuit Family was approved for sale with LICENSALE.COM®. ...

    Read More
  • Jul 17 2017
    NETHERLANDS TO USE FDA-STYLE UDI SYSTEM FOR MEDICAL DEVICES

    A US-style unique device identification (UDI) coding system for medical devices will be introduced in the Netherlands next year....

    Read More
  • Jul 10 2017
    FDA FINALIZES LIST OF CLASS II DEVICES EXEMPT FROM PREMARKET NOTIFICATION

    The US Food and Drug Administration (FDA) has announced a list of 1,003 class II device types that it believes are sufficiently well understood and do not present risks that require premarket notification review to provide a reasonable assurance of safety...

    Read More
  • Jun 27 2017
    2017 RAPS REGULATORY CONVERGENCE: BOOTH 300/SEPTEMBER 12 LECTURE, 1.15PM

    MedTech regulatory affairs professionals managing the launch of products in new markets and maintaining market approval globally will benefit from the invaluable insights shared during the ‘Regulatory Strategies & Techniques for Faster Market Access’ sess...

    Read More
  • Jun 13 2017
    FDA TO REQUIRE NEW VALIDATION DATA FOR LIST OF REUSABLE MEDICAL DEVICES

    The US Food and Drug Administration (FDA) has unveiled a list of reusable medical devices for which it will require validation data regarding cleaning, disinfection and sterilization as well as validated instructions for use in premarket notification subm...

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP